DEF8, NDUFC2, GUSBP1, ARIH2, STX12 and HIST1H2BN were highly re-expressed (more than 100 folds) in either treatment of MV4-11, have not been previously discussed on their role in cancer except for HIST1H2BN. This evidence concerns the gene NDUFC2 and cancer.